NORATA, GIUSEPPE DANILO
NORATA, GIUSEPPE DANILO
Dipartimento di Scienze Farmacologiche e Biomolecolari Rodolfo Paoletti
Development of a human immune system experimental model to investigate immune cells activation and targeting for CVD
2026 A. Moretti, S. Greco, A. Moregola, S. Della Bella, S. Balin, G.B. Vingiani, C.J. Binder, F. Porsch, G.D. Norata, F. Bonacina
SREBP1c Modulates Treg Immunobiology Through a Phospholipid-Dependent Adenosine Pathway
2026 F. Bonacina, C. Procaccini, M. Iaia, A. Moretti, M. Svecla, S. Pedretti, J. Bogie, G.B. Vingiani, A. Moregola, F. Genova, C. Russo, G.D. Rosa, C.L. Rocca, G. Mondanelli, M. Gargaro, N. Mitro, G. Matarese, G.D. Norata
Hdac3 shapes adipocyte size, death susceptibility, macrophage turnover, and vascular remodeling in a mouse model of obesity
2026 L. Coppi, I. Severi, F. Bonacina, S. Villa, C. Peri, R. Longo, M. Senzacqua, J. Perugini, C. Galli, S. Pedretti, N. Mitro, A.L. Catapano, G.D. Norata, A. Giordano, E. De Fabiani, M. Crestani
Long-lasting Glucocorticoid and Immune Dysregulation sustain Anorexia Nervosa Beyond Weight Recovery
2026 F. Mottarlini, L. Da Dalt, S. Parolaro, A. Baragetti, B. Rizzi, S. Taddini, L. Rapini, A.C. Cigognini, F. Vairano, S. Bertelli, A. D’Agostino, F. Bonacina, G.D. Norata, F. Fumagalli, L. Caffino
Cocaine exposure during adolescence impairs stress induced behavioral and immune responses
2026 P. Miglioranza, L. Da Dalt, S. Parolaro, B. Rizzi, S. Taddini, A. Moregola, G.D. Norata, L. Caffino, F. Fumagalli, F. Mottarlini
Associations of the triglyceride-glucose index and its obesity-related derivatives with cardiac structure, function, and incident atrial fibrillation: a prospective cohort study using cardiac magnetic resonance
2026 Z. Fan, T. Shi, C. Yang, T. Zheng, M. Sieme, B. Sasko, J. Wintrich, M. Khan, X. Liu, A. Aweimer, A. Mügge, P. Maffia, P. Pellicori, I. Akin, L. Van Heerebeek, I. El-Battrawy, U. Schotten, G.D. Norata, F. Paneni, J. Yang, N. Hamdani
Circulating cardiometabolic metabolite profiles associated with ambient air pollution and atrial fibrillation risk: a prospective cohort study
2026 T. Shi, C. Yang, Z. Fan, M. Sieme, M. Tangos, X. Wu, M. Lin, D. Huang, B. Sasko, J. Wintrich, M. Khan, X. Liu, A. Aweimer, A. Mügge, I. Akin, L. Van Heerebeek, I. El-Battrawy, G.D. Norata, U. Schotten, F. Paneni, K. Huang, J. Yang, N. Hamdani
Impact of incretin analogues on lipid and lipoprotein metabolism in obesity and diabetes
2026 A. Baragetti, G.D. Norata
Cellular Interactions and Immunometabolic Mechanisms in Heart Failure With Preserved Ejection Fraction: From Molecular Mechanisms to Clinical Evidence
2026 A. Peikert, A. Vacca, G.D. Norata, G.G. Schiattarella, E. Osto
Deletion of MMP12 improves energy metabolism and brown adipose tissue function in mice prone to cardiometabolic disease
2026 M. Amor, M. Diaz, A. Fuerlinger, M. Svecla, V. Bianco, L. Schooltink, A. Dobrijević, B. Schwarz, A. Akhmetshina, N. Vujić, M. Korbelius, M. Hirtl, M. Buerger, A. Pirchheim, S. Rainer, S. Schauer, G. Beretta, W. Goessler, D. Kolb, G. Hoefler, H. Hackl, C. Madreiter-Sokolowski, M. Abdellatif, G.D. Norata, D. Kratky
Immune-metabolic characterization of a humanized mouse model for translational studies on cardiovascular diseases
2025 A. Moretti, S. Greco, A. Moregola, C.J. Binder, F. Porsch, G.D. Norata, F. Bonacina
Metabolic reprogramming of naïve regulatory T cells by IL-7 and IL-15 promotes their persistence and performance upon adoptive transfer
2025 J. Filoni, A. Ferrari, T. Jofra, A.R. Putignano, L. Da Dalt, S. Cesarano, C. Di Dedda, F. Bonacina, F. Marchesi, D. Norata, C. Bonini, L. Piemonti, P. Monti
Irisin-BDNF neurometabolic pathway disruption in the Activity-Based Anorexia model
2025 S. Parolaro, F. Mottarlini, L. Da Dalt, B. Rizzi, S. Taddini, F. Bonacina, F. Vairano, A. D’Agostino, S. Bertelli, G.D. Norata, F. Fumagalli, L. Caffino
Neuroimmune dysregulation in the activity-based anorexia model
2025 S. Parolaro, F. Mottarlini, L. Da Dalt, A. Baragetti, B. Rizzi, F. Bonacina, G.D. Norata, F. Fumagalli, L. Caffino
Peripheral and central dysregulation of the immune system in the Activity-Based Anorexia model
2025 S. Parolaro, F. Mottarlini, L. Da Dalt, A. Baragetti, B. Rizzi, F. Bonacina, G.D. Norata, F. Fumagalli, L. Caffino
Targeting PCSK9 beyond the liver: evidence from experimental and clinical studies
2025 L. Da Dalt, A. Baragetti, G. Norata
D-lactate and glycerol as potential biomarkers of sorafenib activity in hepatocellular carcinoma
2025 S. Pedretti, F. Palermo, M. Braghin, G. Imperato, P. Tomaiuolo, M. Celikag, M. Boccazzi, V. Vallelonga, L. Da Dalt, G.D. Norata, G. Marisi, I.G. Rapposelli, A. Casadei-Gardini, S. Ghisletti, M. Crestani, E. De Fabiani, N. Mitro
Increased mitochondrial fusion via systemic OPA1 overexpression promotes dyslipidemia and atherosclerosis in LDLR deficient mice
2025 L. Da Dalt, F. Fantini, G. Giancane, A. Moregola, S. Roda, M. Svecla, S. Pedretti, G.B. Vingiani, J. Sun, A. Edsfeldt, I. Goncalves, P. Uboldi, E. Donetti, A. Baragetti, N. Mitro, L. Scorrano, G.D. Norata
The new generation of small interfering RNAs directed against apoprotein(a): focus on the safety and efficacy of zerlasiran and lepodisiran
2025 A. Baragetti, G. Norata
Immune-metabolic characterization of a humanized mouse model for translational studies on cardiovascular diseases
2025 A. Moretti, S. Greco, A. Moregola, C.J. Binder, F. Porsch, G.D. Norata, F. Bonacina